Diagnostic dynamic contrast-enhanced magnetic resonance imaging blood-brain barrier assessment combined with plasma biomarkers for mild cognitive impairment

Table 2 Comparison of various scale scores among three groups, mean ± SD

	Control group (n = 55)	na-MCI group (n = 50)	a-MCI group (n = 52)	F value	P value
MoCA	28.05 ± 0.85	21.86 ± 2.05a,1	21.23 ± 2.13a,1	247.0	< 0.0001
AVLT-H-N5	6.16 ± 1.44	2.24 ± 0.69a,1	2.31 ± 0.58a,1	275.8	< 0.0001
HAMA	3.31 ± 2.10	5.16 ± 1.02a,1	7.06 ± 1.00a,1,2	85.25	< 0.0001
HAMD	1.95 ± 0.23	6.00 ± 0.64a,1	7.15 ± 0.61a,1,2	1488	< 0.0001
ADL	23.09 ± 1.17	26.24 ± 1.55a,1	28.58 ± 1.21a,1,2	234.9	< 0.0001

^aP < 0.05.

¹P vs control group.

²P vs non-amnestic mild cognitive impairment group.

MoCA: Montreal cognitive assessment; AVLT-H-N5: Auditory verbal learning test-Huashan version delayed recall score (N5 dimension); HAMA: Hamilton anxiety scale; HAMD: Hamilton depression scale; ADL: Activity of daily living; a-MCI: Amnestic mild cognitive impairment; na-MCI: Non-amnestic mild cognitive impairment.